EMERGE 2050 speakers are leading industry visionaries at the sharp edge of where health and technology are converging
The two-day conference and networking event will be presented by the leading names in Capital Investment in health-tech innovation internationally, supported by tech innovators, many of whom have gone on to achieve US$ multi-million valuations, or so-called unicorn status, with a ticket price of US$1billion plus.
Regional & global thought leaders at EMERGE 2050

Ahmed Al-Bader
Co-Founder & CEO, SihaTech.com

Obediah Ayton
Director, Dhabi Hold Co
Mussaad Al Razouki
Chief Investment & BDO, Kuwait Life Sciences Company

Viktoriya Vasilenko
Founder & CEO, Knowledge Gate Group

Abhishek Shah
Founder & CEO,
Wellthy Therapeutics

Ihsan Jawad
General Partner,
STV

Mohamed Gamal
Group Information Technology Director, United Eastern Medical Services (UEMedical)
Edward Kliphuis
Partner, Sofinnova Partners

Cesare Magri
Founder,
4BetterDevices GmbH

Mark Krul
Founder,
Aglaia Management B.V.

Unmesh Lal
Global Director – Healthcare & Life Sciences Frost & Sullivan

Hakan Esin
Director,
Diginova Health Solutions

Dr. Sarper Tanli
Managing Director MEA
Mass General Brigham
Yoram Wijngaarde
Founder and CEO, Dealroom.co

Jeffrey A. Stephens
General Partner,
Infusion 51a

Filippo Castiglione
Executive Director,
Technology Innovation Institute

Ayoub Glia
Postdoctoral Research Associate,
Celltiro

Faisal A. AlHusry
Principal,
Hikma Ventures
Sophie Smith
Founder and CEO, Nabta Health

Dr. Sadyk Gusniev
Health Tech Expert & Researcher

Clara Roche
Manager – Health Policy & Insights, Economist Impact

Panos Lioulias
Founder, Uni.Fund

Dr Glen Hagemann
Director, Mediclinic Middle East

Diego Palacio
Chief Commercial Officer, Coat Connect
The two-day conference and networking event will be presented by the leading names in Capital Investment in health-tech innovation internationally, supported by tech innovators, many of whom have gone on to achieve US$ multi-million valuations, or so-called unicorn status, with a ticket price of US$1billion plus.
More speakers to be announced. Stay tuned!
“This show is absolutely amazing”
Jeffrey Stephens, Chief Investment Officer, Infusion 51a LP